Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts
Overview
Affiliations
Tumor immune infiltration plays a key role in the progression of solid tumors, including ovarian cancer, and immunotherapies are rapidly emerging as effective treatment modalities. However, the role of cancer-associated fibroblasts (CAFs), a predominant stromal constituent, in determining the tumor-immune microenvironment and modulating efficacy of immunotherapies remains poorly understood. We have conducted an extensive bioinformatic analysis of our and other publicly available ovarian cancer datasets (GSE137237, GSE132289 and GSE71340), to determine the correlation of fibroblast subtypes within the tumor microenvironment (TME) with the characteristics of tumor-immune infiltration. We identified (1) four functional modules of CAFs in ovarian cancer that are associated with the TME and metastasis of ovarian cancer, (2) immune-suppressive function of the collagen 1,3,5-expressing CAFs in primary ovarian cancer and omental metastases, and (3) consistent positive correlations between the functional modules of CAFs with anti-immune response genes and negative correlation with pro-immune response genes. Our study identifies a specific fibroblast subtype, fibroblast functional module (FFM)2, in the ovarian cancer tumor microenvironment that can potentially modulate a tumor-promoting immune microenvironment, which may be detrimental toward the effectiveness of ovarian cancer immunotherapies.
Kumar V, Tomar A, Thapliyal A, Yadav S Biochem Res Int. 2024; 2024:4288753.
PMID: 39309198 PMC: 11415250. DOI: 10.1155/2024/4288753.
Guo Y, Zhou Q, Wei M, Fan J, Huang H Heliyon. 2024; 10(7):e28445.
PMID: 38560169 PMC: 10979244. DOI: 10.1016/j.heliyon.2024.e28445.
Fang Y, Xiao X, Wang J, Dasari S, Pepin D, Nephew K NPJ Precis Oncol. 2024; 8(1):7.
PMID: 38191909 PMC: 10774407. DOI: 10.1038/s41698-023-00495-5.
Li Y, Ochoa C, Zhu Y, Kramer A, Wilson M, Fang Y iScience. 2023; 26(10):107952.
PMID: 37810241 PMC: 10558812. DOI: 10.1016/j.isci.2023.107952.
Huang H, Yu H, Li X, Li Y, Zhu G, Su L Front Immunol. 2022; 13:993890.
PMID: 36505472 PMC: 9732939. DOI: 10.3389/fimmu.2022.993890.